Queensland biotechnology company Vaxxas has raised $25 million in a Series B funding round, which will be used to advance clinical trials of its innovative technology that could one day lead to the end of the vaccine syringe.
Zero Co’s staggering $5 million crowd-funding raise was over in just six hours
Proptech BuildPass raises $1 million to make construction management easier
VC Square Peg backs waste reduction startup Zero Co in $6 million raise ahead of record-breaking $5m crowd-funding campaign
Startup Daily TV: Zero Co founder Mike Smith on his eco-startup’s record-breaking $5 million crowd-funding campaign
Daily startup news and insights, delivered to your inbox.
